Tylenol Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of First Bellwether Trial in Federal Tylenol Litigation

Share Article

The outcome of bellwether trials may provide valuable insight into jury rulings in other Tylenol lawsuits alleging acetaminophen-induced liver damage.

Free Case Review
The outcome of this case may provide valuable insight into jury rulings in other Tylenol lawsuits involving liver damage allegations.

Tylenol lawsuits (http://www.tylenollawsuitcenter.com/) filed on behalf of individuals who allegedly suffered acetaminophen-induced liver damage continue to move forward in the federal multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania. According to a Case Management Order issued on January 29th, the proceeding’s first bellwether trial will commence on June 22, 2015. The case selected for trial was brought by the sister of a woman who died as a result of acute liver failure, allegedly due to the acetaminophen in Extra Strength Tylenol. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

“Bellwether trials are a vital part of large, complex litigations such as the one involving Tylenol. The outcome of this case may provide valuable insight into jury rulings in other Tylenol lawsuits involving liver damage allegations,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free legal reviews to consumers who were allegedly harmed by a Tylenol-brand over-the-counter medication.

Tylenol Litigation
According to court documents, more than 160 Tylenol liver damage claims are currently pending in the litigation underway in Pennsylvania, all of which allege that Johnson & Johnson and McNeil Consumer Healthcare failed to provide consumers with adequate warnings regarding the risks associated with Tylenol-brand medications. Among other things, the lawsuits claim that liver damage related to Tylenol products can occur even when the medication is used in accordance with label directions, and can be severe enough to result in hospitalization, liver transplantation, or death.

Last Fall, a Consumer Reports investigation revealed that acetaminophen-induced liver damage sends more than 80,000 people to the emergency room every year. Among other things, the report detailed one study which suggested that exceeding just 4,000 milligrams of acetaminophen for just a few days can result in serious liver problems and other complications. Yet the daily limits recommended for many over-the-counter acetaminophen products come very close to this threshold.*

In August 2013, McNeil Consumer Healthcare announced that it would add new, more prominent warnings regarding the risk of liver damage to the labels of Tylenol-brand medications. However, according to Bloomberg.com, over-the-counter Extra Strength Tylenol caplets each contain 500 mg of acetaminophen, which is higher than the current limits set by federal health regulators for prescription medications that contain this active ingredient.**

Individuals who suffered serious liver damage allegedly related to the acetaminophen in a Tylenol medication may be entitled to compensation for their injury-related damages. To learn more about the potential link between Tylenol and liver damage, please visit Bernstein Liebhard LLP's website. Free, confidential and no-obligation case reviews are available by calling 800-511-5092.

*newsnet5.com/money/consumer/consumer-specialist/warning-about-acetaminophen-consumer-reports-investigates, Consumer Reports (via 5 ABC News) October 29, 2014
** bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website